Company Financials

Moderna, Inc. Financials

United States dollar

business Moderna, Inc. Company Profile

Main Stock Listing

NASDAQ: MRNA

Market Capitalization $11.71 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 24.97
Forward PE -3.48
Price to Sales TTM $3.69
Price to Book MRQ $1.16
Enterprise to Revenue 1.71
Enterprise to EBITDA -1.54

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin -105.67%
Operating Margin -972.22%
Return on Assets TTM -15.84%
Return on Equity TTM -29.34%

Income Statement

Revenue TTM $3,176,999,936
Revenue per Share TTM $8.25
Quarterly Revenue Growth -35.30%
Gross Profit TTM $-2,616,999,936
EBITDA $-3,536,999,936
Net Income to Common TTM $-3,356,999,936
Diluted EPS TTM $-8.73
Quarterly Earnings Growth YoY -35.93%

Balance Sheet

Total Cash MRQ $5,975,000,064
Total Cash per Share MRQ $15.45
Total Debt MRQ $
Total Debt to Equity MRQ 7.40
Current Ratio MRQ 4.22
Book Value per Share MRQ $26.01

Cash Flow

Operating Cash Flow TTM $-3,052,000,000
Levered Free Cash Flow TTM $-3,197,499,904

MRNA Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 386,000,000
Float Shares 360,977,080
Avg 10 Volume 10,218,184
Avg 30 Volume None
Shares Short 63,564,116
Short Ratio 4.88
Short % of Shares 22.82%
% Held by Insiders 7.28%
% Held by Institutions 73.67%

Stock Price Summary

Beta 1.86
Fifty Two Week Low $23.15
Fifty Two Week High $129.39
Fifty Two Week Change -288.06%
Day 50 MA $26.50
Day 200 MA $38.60

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date